by Team Small News | Dec 14, 2025 | Dr Reddy's
The US Food and Drug Administration (FDA) has approved two new oral medicines, Nuzolvence (zoliflodacin) and Blujepa (gepotidacin), to treat gonorrhea, a common sexually transmitted infection (STI) that is increasingly resistant to existing treatments. The World...
by Team Small News | Dec 9, 2025 | Dr Reddy's
Dr. Reddy’s Laboratories and Immutep Limited have formed a strategic partnership to develop and commercialize Eftilagimod alfa, a novel immunotherapy treatment. The partnership aims to accelerate the development and availability of this promising therapy for...
by Team Small News | Dec 5, 2025 | Dr Reddy's
An Indian court has ruled in favor of Dr. Reddy’s Laboratories, allowing the company to manufacture and export generic versions of Novo Nordisk’s popular diabetes and weight-loss medications, Ozempic and Wegovy. The key ingredient in these drugs is...
by Team Small News | Dec 3, 2025 | Dr Reddy's
The Delhi High Court has ruled in favor of Dr. Reddy’s Laboratories, allowing the company to manufacture and export its version of the diabetes and anti-obesity drug semaglutide, while restricting domestic sales until 2026. The decision comes in a patent...
by Team Small News | Dec 2, 2025 | Dr Reddy's
Dr. Reddy’s Laboratories has promoted Manish Shukla to the position of Global Head of HR – Corporate and Head of HR Strategy. This move is part of the company’s efforts to strengthen its global people agenda and enhance its strategic HR capabilities...
by Team Small News | Nov 30, 2025 | Dr Reddy's
Dr. Kishore B Reddy, a renowned orthopedic oncologist and Managing Director of Amor Hospital, has been invited to speak at the prestigious international conference, BOSCON 2025, organized by the Bangladesh Orthopedics Society. The two-day event will take place in...